DACH Biotech is a healthcare innovation company focused on early disease detection, with an emphasis on biotechnology and AI-enabled diagnostic platforms.
Developing diagnostic platforms that combine biotechnology, artificial intelligence and digital health, with a strong focus on prostate cancer.
Building scalable and affordable solutions that can be integrated into different healthcare environments.
Focusing on dependable diagnostic performance and practical workflows for clinical decision-making.
Started as a research-driven initiative focused on biotechnology and diagnostics.
Expanded toward scalable testing solutions and AI-supported diagnostic approaches.
Continues to bridge science, technology and real-world healthcare needs.
Co-Founder
Background in cancer biology, chemoprevention and therapeutics, with experience leading research projects.
Co-Founder
Focused on early diagnostics and startup innovation, including work supported through entrepreneurship initiatives.